Can ESMA DeFi regulation uncertainty fuel Morpho rally?

Can ESMA DeFi regulation uncertainty fuel Morpho rally?
Morpho surges 7.72% to $2.73 today

Morpho (MORPHO) is trading at $2.735, marking a daily gain of 7.72%. The asset trades above its key moving averages, supporting a bullish structure in the current session.

MORPHO price prediction
24H 2.05%
$2.1767
48H 1.61%
$2.1673
7D -0.91%
$2.1136
1M -26.27%
$1.5726
3M -24.72%
$1.6057
6M 74.19%
$3.7155
12M 559.42%
$14.0655
Current price: $2.133 -0.079 3.57%
Real-time Data 08:22
Daily range 2.1067 Arrow from to Icon 2.187
Weekly range 1.9587 Arrow from to Icon 2.4260
Loading...

Highlights

  • Morpho leadership expresses concern that proposed ESMA DeFi rules under MiCA could result in overlapping regulatory requirements and uncertainty.
  • The company’s compliance posture and potential changes in operational costs have drawn renewed market attention and increased asset demand.
  • Morpho trades inside a strong short- and medium-term uptrend, with price at $2.735 and an expected range of $2.6505 to $2.8195 for the next 2 to 3 days, but short-term indicators warn of overbought conditions.

Regulatory uncertainty drives demand amid industry compliance concerns

The public affairs director of Morpho has raised concerns that the European Securities and Markets Authority's proposed enhancements to DeFi regulations under the MiCA framework could introduce overlapping and redundant requirements for the platform, according to Cryptoast. This direct commentary from company leadership highlights regulatory uncertainty, prompting renewed market focus on Morpho's compliance posture. As traders assess the potential ramifications for operational costs and future DeFi participation, the news has contributed to heightened demand for the asset.

Morpho asset chart
Morpho price dynamics. Source: TradingView.

Overbought signals intensify as bullish momentum surpasses technical thresholds

On the technical front, Morpho remains above the MA-20 at $2.6085 and MA-50 at $2.5983 on the hourly chart, clearly exceeding the daily MA-200 at $2.0307. Immediate support sits at the Ichimoku Kijun on the daily timeframe at $2.63. Momentum indicators continue to favor buyers: both MACD and ADX signal bullish momentum, while Bull/Bear Power shows intraday strength from buyers and the Awesome Oscillator also confirms upside trend direction. Oscillator readings warn of overbought conditions, with RSI in positive territory and both Stoch RSI and CCI registering extreme, short-term overheating.

Sideways range expected as upside potential outweighs limited downside risk

Over the coming 2–3 trading days, Morpho is forecast to fluctuate within the $2.6505 to $2.8195 range, reflecting the typical volatility band relative to current levels. The probability of a further upward move is very high, while downside risk remains low. The primary scenario calls for sideways action within the established corridor; a move above resistance would open up a bullish breakout, while a breach of immediate support at $2.63 would trigger a bearish response.

Anton Kharitonov, expert at Traders Union, sees Morpho holding bullish momentum above key technical levels, but notes the backdrop of regulatory uncertainty following the company’s recent public warnings. He believes increased attention around ESMA’s MiCA proposals is driving short-term demand, yet operational and compliance risks remain a concern. The primary scenario is sideways movement between $2.6505 and $2.8195, with overbought indicators calling for caution. "Until the regulation picture clarifies and $2.63 support is respected, I remain neutral and advise vigilance on swift position changes."

Earlier, analysts noted that Morpho had shifted into a bullish technical posture following a period of governance concerns and liquidity stress. The current analysis adds a new regulatory dimension amid continued technical strength, with the $2.63 support level emerging as a critical threshold for traders assessing short-term downside risk.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.